ΠΑΡΟΥΣΙΑΣΗ ΕΡΓΑΣΙΩΝ ΣΕ ΔΙΕΘΝΗ ΣΥΝΕΔΡΙΑ

1. Smoking influences intragastric Helicobacter pylori density before and after eradication therapy in duodenal ulcer patients.Κ. Patikos, K. Triantafyllou, M. Tzouvala, G. Katsoras, M. Mylonaki, Zizi-Serbetzoglou, I. Elemenoglou, D.G. Karamanolis. XXV TH Balkan Medical Week, Ioannina, 1-4/07/1998. Αρχεία Ελληνικής Ιατρικής 1998; 15(Συμπλ Α): Α261, Ο39

2. Does H. pylori influence the number of relapses of ulcerative colitis? M. Tzouvala, M. Mylonaki, K. Triantafyllou, E. Tsironi, E. Varvate-Koutsoukou, G. Varvayiannis, C. Nicolopoulou, , D.G. Karamanolis. World Congress of Gastroenterology, 6-11/9/1998, Vienna, Austria. Digestion 1998; 59(suppl 3): 151: FoLM1352.

3. Predictive factors of post-treatment diagnostic accuracy of CLO-test in duodenal ulcer patients. K. Triantafyllou, Κ. Patikos, G. V. Papatheodoridis, M. Mylonaki, D. Zisis, V. Xourgias, D.G. Karamanolis. World Congresses of Gastroenterology, 6-11/9/1998, Vienna, Austria. Digestion 1998; 59(suppl 3): 424: ExhB3181 16

4. Inflammatory Bowel Disease haunted by Cytomegalovirus infection. Κ. Patikos, M. Tzouvala, M. Mylonaki, Ch. Poulopoulou, K. Triantafyllou, V. Xourgias, D.G. Karamanolis. 7 th United European Gastroenterology Week 13 – 17 November 1999, Rome Italy. Gut 1999; 45(suppl V): P 1052

5. bcl-2, p53 and mdm2 protein expression in gastritis, dysplasia and gastric adenocarcinoma K. Triantafyllou, M. Tzouvala, N. Kapranos, G. V. Papathodoridis, A. Zizi, M. Mylonaki, D.G. Karamanolis. Digestive disease week meeting, 1999 Gastroenterology 1999;116(4)G1941

6. Should colonoscopy be performed in all patients with non – advanced rectosigmoid adenomas? Κ. Patikos, M. Mylonaki, E. Tsironi, M. Michael, D. Zisis, D.G. Karamanolis. 1ST European Congress on Gastrointestinal Oncology, Kos, Greece, 22-25/06/2000. Annals of Gastroenterology 2000; 13(suppl 1): 16(p.130)

7. How often an advanced neoplasia exists in the proximal colon without an index polyp in the rectosigmoid? Κ. Patikos, M. Mylonaki, E. Tsironi, M. Tzouvala, K. Triantafyllou, V. Xourgias, D.G. Karamanolis. 1 ST European Congress on Gastrointestinal Oncology, Kos, Greece, 22-25/06/2000. Annals of Gastroenterology 2000; 13(suppl 1): 70 (p. 157)

8. Does gastritis after H. Pylori eradication in patients with duodenal ulcer correlate with dyspeptic symptoms? K. Patikos, K. Triantafyllou, M.Tzouvala, M. Mylonaki, E. Tsironi, B. Xourgias, D.G. Karamanolis. 8 th United European Gastroenterology Week, Brussels, 25 – 30/11/2000. Gut 2000; 47(suppl 3): A122.

9. Ιs there a relationship between H. Pylori and bleeding in NSAIDS user patients, with peptic ulcer? M.Tzouvala, K. Patikos, M. Mylonaki, E. Tsironi, B. Xourgias, D.G. Karamanolis. 8 th United European Gastroenterology Week, Brussels, 25 – 30/11/2000. Gut 2000; 47(suppl 3): A86

10. Οbjective measures using image analysis in bleeding peptic ulcers. B. Xourgias, K. Patikos. E. Tsironi, M. Mylonaki, G. Giogas, D.G. Karamanolis. 8 th United European Gastroenterology Week, Brussels, 25 – 30/11/2000. Gut 2000; 47(suppl 3): E28.

11. Does cure of the H. Pylori infection induce gastroesophageal reflux symptoms in patients with duodenal ulcer? B. Xourgias, K. Triantafyllou, M. Mylonaki, 17 G. Katsoras, D.G. Karamanolis. Digestive Disease Week meetings May 21-24, 2000 San Diego. Gastroenterology 2000; 118(suppl 2): 6048.

12. Adherent microbial populations in inflammatory bowel disease. N. B Rayment, M. Mylonaki, B.N Hudspith, K. Bruce, D. S Rampton, J. Brostoff Annual Congress of the British Society for Immunology, 4-7/12/2001, Harrogate,UK. Immunology 2001; 104(suppl 1):OP177

13. Prevalence of usage and tolerance of oral iron therapy in inflammatory bowel disease: are we using it appropriately and could we do better? A D. De Silva, M. Mylonaki, D S. Rampton. British Society of Gastroenterology Annual Meeting, Glasgow, 18-21/03/2001. Gut 2001; 48 (suppl 1): A88.

14. Efficacy and usage of oral iron therapy in Inflammatory Bowel Disease. A D. De Silva, M. Mylonaki, D S. Rampton. Digestive Disease Week meetings, May 21-24, 2001, Atlanta, Gastroenterology 2001; 120(suppl 1): 1393

15. Reduced Bifidobacteria and increased E.coli in rectal mucosa – associated flora in active inflammatory bowel disease. N. Rayment, M. Mylonaki, B. Hudspith, J. Brostof, D. Rampton. British Society of Gastroenterology, Annual meeting, 18 – 21/3/2002 Oral presentasion during the Inflammatory Bowel Disease Symposium: ‘Gut flora in IBD – Practical Importance Gut 2002; 50 (suppl II): A29.

16. ASCA and ANCA in the diagnosis of inflammatory bowel disease and other diarrhoeal illnesses. M. Buckland, M. Mylonaki, D. S. Rampton, H. J. Longhurst. British Society of Gastroenterology, Annual meeting, 18 – 21/3/2002. Gut 2002; 50 (suppl II): A67

17. Clinical results of wireless capsule endoscopy. Mylonaki M, Fritscher – Ravens A, Swain P. British Society of Gastroenterology, Annual meeting, 18 – 21/3/2002 Oral presentasion. Gut 2002; 50 (suppl II): A17

18. Clinical studies of wireless capsule colonoscopy. Mylonaki M, Fritscher – Ravens A, Lewkowicz S, Swain P. British Society of Gastroenterology, Annual meeting, 18 – 21/3/2002 Oral presentasion, Gut 2002; 50 (suppl II): A42

19. Increasing risk of Clostridium Difficile infection in patients presenting with relapse of inflammatory bowel disease. M. Mylonaki, F. Johnson, L. Langmead, D. Rampton. Digestive Disease Week meetings, 19-22/5/2002, San Francisco, Gastroenterology 2002; 122 (suppl 1): W1307 18

20. ASCA and ANCA in the diagnosis of Inflammatory Bowel Disease and other diarrhoeal illnesses. M. Buckland, M. Mylonaki, D. S. Rampton, H. J. Longhurst. Digestive Disease Week meetings, 19-22/5/2002, San Francisco Gastroenterology 2002; 122 (suppl 1): S1183

21. ANCA/ASCA profile in the prediction of clinical phenotype in Crohn’s disease. M. Mylonaki, M. Buckland, H. Longhurst, A.D. de Silva, A. B. Ballinger, D. Rampton. Digestive Disease Week meetings, 19-22/5/2002, San Francisco, Gastroenterology 2002; 122 (suppl 1): S1185 22. Clinical results of wireless capsule endoscopy. M. Mylonaki, A. Fritscher – Ravens, P. Swain. Digestive Disease Week meetings, 19-22/5/2002, San Francisco, Gastrointestinal Endoscopy 2002; 55 (5): M2026

23. The effects of stress on gastrointestinal physiology using wireless capsule endoscopy observation. Fritscher – Ravens, M. Mylonaki, P. Swain. Digestive Disease Week meetings, 19-22/5/2002, San Francisco Gastrointestinal Endoscopy 2002; 55 (5): M1968.

24. Invasive microbial populations in inflammatory bowel disease G. Shah, N. B. Rayment, M. Mylonaki, B. N. Hudspith, D. S. Rampton, J. Brostoff. Joint Congress of the British Society for Immunology and the British Society for Allergy and Clinical Immunology, 3-6/12/2002, Harrogate, UK Immunology 2002; 107(suppl 1):OP148.

25. Co-localisation of E.coli with macrophages in lamina propria in patients with active inflammatory bowel disease (IBD). N. Rayment, M. Mylonaki, D. Rampton, B. Hudspith, J. Brostoff. British Society of Gastroenterology, Annual meeting, Birmingham 23 – 26/3/2003. Οral presentation. Gut 2003; 52: (1) 049.

26. Co-localisation of E.coli with macrophages in lamina propria in patients with active inflammatory bowel disease (IBD). N. Rayment, M. Mylonaki, D. Rampton, B. Hudspith, J. Brostoff. 3 rd International Inflammatory Bowel Disease Meeting, Chester, 9-11/2/2003. Οral presentation. Aliment Pharmacol Ther 2003.

27. Risk of cervical intraepithelial neoplasia is not increased in patients on thiopurines for inflammatory bowel disease (IBD). M. Mylonaki, U. Menon, I. Jacobs, A. Ballinger, D. Rampton. 3 rd International Inflammatory Bowel 19 Disease Meeting, Chester, 9-11/2/2003. Accepted as a poster. Aliment Pharmacol Ther 2003.

28. ANCA AND ASCA profile in Bangladeshi patients with inflammatory bowel disease. E. Tsironi, M. Mylonaki, M. Buckland, H. Longhurst, D. Rampton. 3 rd International Inflammatory Bowel Disease Meeting, Chester, 9-11/2/2003. Accepted as a poster. Aliment Pharmacol Ther 2003.

29. Development and testing of an electrically propelled capsule endoscope in man. Fritcher-Ravens A, Burke P, Mills T, Mosse CA, Mylonaki M, Swain CP. Digestive Disease Week meetings, 17-22/5/2003, Orlando, Florida. Abstracts book: 486, A-100. Gastrointestinal Endoscopy 2003; 57 (5): AB84.

30. Wireless capsule endoscopy in children: A study to access the diagnostic yield in small bowel disease in paediatric patients.Furman MA, Mylonaki M, Fritcher-Ravens A et al. Digestive Disease Week meetings, 17-22/5/2003, Orlando, Florida. Abstracts book: 565, A-115 .Gastrointestinal Endoscopy 2003; 57 (5): AB89.

31. Profiling the bacterial community associated with the rectal mucosa in inflammatory bowel disease (IBD) using 16S rDNA denaturing gradient gel electrophoresis. Green G, Mylonaki M, Rampton D, et al. Digestive Disease Week meetings, 17-22/5/2003, Orlando, Florida. Abstracts book: T1067, A670. Gastroenterology 2003; 124 (4), Page A478.

32. Co- localisation of E. coli with macrophages in lamina propria in patients with active inflammatory bowel disease (IBD). Rayment N, Mylonaki M, Rampton D, et al. Digestive Disease Week meetings, 17-22/5/2003, Orlando, Florida Abstracts book: T1076, A-672. Gastroenterology 2003; 124 (4), Page A479.

33. Co-localisation of E.coli with macrophages in lamina propria in patients with active inflammatory bowel disease (IBD). Rayment NB, Mylonaki M, Hudspith B, Brostoff J. Inflammatory Symposium ‘Inflammatory Bowel Disease, from the bench to bedside – Crete 2003’. June 27-28 2003. Abstracts book, P101, σελ 40.

34. Experimental and clinical studies of wireless capsule colonoscopy. Swain P, Fritscher-Ravens A, Mylonaki M. Digestive Disease Week meetings, 1520/5/2004, New Orleans. Abstracts book: 464, A-96. Oral presentation. Gastrointestinal Endoscopy 2004; 59 (5): 464, AB 103, σελ 464.

35. The assessment of wireless capsule endoscopy in paediatrics. Furman MA, 20 Mylonaki M, Heuschkel R et al. Digestive Disease Week meetings, 1520/5/2004, New Orleans. Abstract book: M1820, A-546) Gastroentestinal Endoscopy 2004; 59 (5): Page 176.

36. Co-localization of E.coli within lamina propria macrophages to phagosomes in active inflammatory bowel disease. Rayment N, Petrovsca L, Dougan G, Hudspith B, Brostof J, Mylonaki M, Rampton DS. 1st Joint AGA-BSG Research Meeting: Pathogenesis of IBD, Oxford 2004.

37. Co-localization of E.coli within lamina propria macrophages to phagosomes in active inflammatory bowel disease. Rayment N, Petrovsca L, Dougan G, Hudspith B, Brostof J, Mylonaki M, Rampton DS. Annual Congress of the British Society for Immunology 2004, Harrogate, UK. Immunology 2004; 113 (suppl 1).

38. Molecular characterisation of the Bacteria adherent to human colorectal mucosa.Green G, Brostoff J, Hudspith B, Michael M, Rayment N, Mylonaki M, Sanderson J, Staines N, Rampton D, Bruce K. Digestive Disease Week meetings, 14-19/5/2005, Chicago IL. (S1332, A-195) Gastroenterology 2005; 128 (4) (suppl 2): S1332, page A-195.

39. Primary esophageal melanoma (EM): Diagnostic and therapeutic manipulations. Cherakakis P, Tzouvala M, Parasi A, Karambelis A, Cherakakis, Mylonaki M, Mastrangelis A, Triantafillidis AJ, Triantafillidis JK. 2 nd International Congress on Gastrointestinal Oncology, 23-25 June 2005. Santorini Island Greece. Ann Gastroenterol 2005; 18: 265.

40. Early gastric cancer, atrophic gastritis and autoimmune hepatitis in the same patient: a very rare combination. M Mylonaki, M Sklavena, Α. Μastrangelis, F.Georgopoulos, A Parasi, G Drakoulis, G Peros, P Cheracakis, JK Triantafilli dis ακάκης. Digestive Oncology 2007.

41. Co-localisation of toll-like receptors with signalling molecules IRAk and NFkβ in colonic biopsies of patients with inflammatory bowel disease. De Costa A, Rayment N, Mylonaki M, Petrovska L, Hudspith B, Brostof J, Nunes C, Parkes G, Sanderson JD, Rampton DS. British Society of Gastroenterology, Annual meeting, Glasgow 23 – 26/3/2006. Gut 2006; 55 (S11): 291, σελ A76.

42. Increased expression of TLRs’ is associated with an upregulation of signalling molecules IRAK-1 and NFkB in colonic biopsies of patients with inflammatory bowel disease. De Costa A, Rayment N, Mylonaki M, et al. Digestive Disease 21 Week meetings 2006, Washington. Abstracts book: M1768. Gastroenterology 2006 (suppl).

43. Infections from viruses, mivrobes and parasites in patients with inflammatory bowel disease: A 15 years experience.JK Triantafillidis, P Cheracakis, M Mylonaki , F Georgopoulos, A Stamataki, G Peros. Journal of Crohn’s and Colitis 2008; 2 (1): 45-46. 3 rd Congress of ECCO, Lyon, France 2008.

44. Epstein-Barr infection of the colon in a patient with severe first attack of ulcerative colitis. P. Cheracakis, Evangelia Dimitroulia, Aikaterini Triantafillidiss, G. Malgarinos, Chrissa Malli, J. Fouskas, V. Panteris, Maria Mylonaki, F. Georgopoulos, J.K. Triantafillidis. 18th International postgraduate course of the International Association of Surgeons, Gastroenterologists and Oncologists. Athens, October 2008 Hepatogastroenterology Supplement I 2008;55:A154 (P109)

45. Efficacy and safety of long-term infliximab administration in a Greek hospital setting. J.K. Triantafillidis, G. Malgarinos, Chrissa Malli, J. Fouskas, Maria Mylonaki, F. Georgopoulos, V. Panteris, P. Cheracakis, G. Peros. 18th International postgraduate course of the International Association of Surgeons, Gastroenterologists and Oncologists. Athens, October 2008. Hepatogastroenterology Supplement I 2008;55:A305 (P478)

46. Intraabdominal abscesses in patients with Crohn’s disease: clinical data and therapeutic manipulations in 17 cases. F. Georgopoulos, J. Fouskas, G. Malgarinos, Chrissa Malli, V. Panteris, Maria Mylonaki, P. Cheracakis, G. Peros, J.K. Triantafillidis. 18th International postgraduate course of the International Association of Surgeons, Gastroenterologists and Oncologists. Athens, October 2008. Hepatogastroenterology Supplement I 2008;55:A306 (P479).